MARGERY WALENTUK: Open Payments
NPI 1720488778 · LYNN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,674 in 166 payments from 13 companies in 2025. Trend: 2023 $332 · 2024 $1,320 · 2025 $3,674
Food & beverage: $3,642Education: $32
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $480 |
| Collegium Pharmaceutical, Inc. | 23 | $477 |
| Neurocrine BioSciences, Inc. | 10 | $396 |
| Alkermes, Inc. | 15 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $360 |
| Lundbeck LLC | 16 | $326 |
| Janssen Pharmaceuticals, Inc | 11 | $322 |
| Vanda Pharmaceuticals Inc. | 21 | $239 |
| Otsuka America Pharmaceutical, Inc. | 9 | $210 |
| ABBVIE INC. | 12 | $203 |
Products named: COBENFY, Jornay PM, REXULTI, INGREZZA, CAPLYTA, FANAPT, INVEGA SUSTENNA, ARISTADA.
Industry payments across MA — which companies pay providers there.
